Profile avatar
anandvkulkarni.bsky.social
Hepatologist at AIG Hospitals, Hyderabad, India. Interests in ALD, ACLF & HCC
17 posts 453 followers 322 following
Regular Contributor
Conversation Starter

With rising burden of metabolic diseases we are struggling with management of ascites in CKD. Here we try to answer them & provide an overview of approach to ascites in ESRD. @ebtapper.bsky.social @akashroyy.bsky.social journals.lww.com/hepcomm/full...

Patients were randomized to FIT vs colonoscopy for colon cancer screening. Participation in any form of screening was 31.8% in the colonoscopy group and 39.9% in the FIT group. 10-year colon cancer mortality risk was 0.22% in colonoscopy arm and 0.24% in FIT arm. www.thelancet.com/journals/lan...

A survey based study from AIG team and UoH on IT individuals who agreed to undergo tests pubmed.ncbi.nlm.nih.gov/40128210/ >80% have fat in liver 20% have elevated liver enzymes 2% have fibrosis (advanced disease) Fatty liver is curable with exercise (150 min/week) and healthy diet #Liversky

Phenomenal

After five decades, steroid dosing in AAH is revisited: Tapered prednisolone proves superior in reducing infections. #STASH trial @jasmohanbajaj.bsky.social @juanpabloarab.bsky.social @ebtapper.bsky.social @tonybreu.bsky.social @blaneymd.medsky.social journals.lww.com/ajg/abstract... #liversky

The latest ACLF guidelines on harmonization of definition - steps from Asia. Joined by all the experts across the globe. Exhaustive recent updates and future directions. @robbrierley.bsky.social @stevenbollipo.bsky.social @liveraim.bsky.social link.springer.com/article/10.1...

📢Thrilled to share our latest review article. Greatful to Prof. Rakhi Maiwall. We explore challenges of managing septic shock in cirrhosis and advocate for personalized approaches pubmed.ncbi.nlm.nih.gov/39744868/ #liversky #Medsky #GIsky @anandvkulkarni.bsky.social

There are *some* people whom steroids help There is still value in trials, pragmatic trials, that refine inclusion criteria, dose, duration, and stopping rules @anandvkulkarni.bsky.social @juanpabloarab.bsky.social @blaneymd.bsky.social

Congrats to inspiring investigators @anandvkulkarni.bsky.social @juanpabloarab.bsky.social and team, for late breaking abstract about rapid taper of steroids in AAH at #TLM24 ⤵️ infections, hospitalizations with rapid taper 💫 changing practice in management of AAH #LiverSky #AASLD

Anand Kulkarni presents data from the STASH trial of dose tapering vs fixed dose corticosteroids in patients with severe alcohol-associated hepatitis #TLM24 #LiverSky

This study by challenges dogma @anandvkulkarni.bsky.social gave a tapering dose of prednisone for alcohol hepatitis instead of 40mg for 28 days And it paid off with fewer infections @tonybreu.bsky.social

Leon Schiff SOA lecture by @jasmohanbajaj.bsky.social on HE @ebtapper.bsky.social #TLM24

Drugs for Mash cirrhosis by Prof Mazen Noureddin #TLM24

Join to learn and discuss about Management of ACLF #Aasld #liversky

I’ll be moderating a webinar tomorrow (Nov 13th) in conjunction with The Hepatitis Fund, as part of London Global Cancer Week 2024. Join us to learn more on how liver cancer can be prevented via the elimination of viral hepatitis! Register: us06web.zoom.us/webinar/regi... #GastroSky #LiverSky

Please put your info in your profile! It really helps decide who to follow

Dr Tapper cares not only for patients but for liver and GI docs. Thank you so much for this- Very useful #liversky @ebtapper.bsky.social

So fun seeing all of my #livertwitter (🪦❔) friends now on #LiverSky (and IRL #TLM24)